Skip to main content
R

Resitu

The startup develops a medical device that utilizes high-resolution ultrasound and a minimally invasive blunt penetration technique with electrocautery energy to perform tumor biopsies. This technology reduces healthcare costs and time while enhancing patient recovery by enabling efficient diagnosis and treatment of breast cancer.

Uppsala, Sweden
Updated 2 months ago

Funding

$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Current breast biopsy methods may require multiple passes, leading to ambiguous tissue analysis and potentially incorrect results. Open surgical procedures can be invasive, increasing patient recovery time and healthcare costs. Existing biopsy techniques may also result in incomplete lesion removal, necessitating revisits and further intervention.

Solution

Resitu Medical is developing a minimally invasive, single-use electrosurgical instrument for obtaining large, intact breast tissue samples for diagnostic analysis. Guided by ultrasound, the device uses a blunt dissection technique combined with diathermy to extract the entire lesion with minimal bleeding. The instrument applies vacuum to draw the lesion into the device, while an electrosurgical electrode severs the tissue. This approach aims to reduce the need for re-sampling, minimize tissue damage, and potentially prevent further lesion development through immediate coagulation. The extracted intact lesion is then sent for histopathological examination, enabling comprehensive analysis, including tumor typing and sequencing.

Target Audience

The primary target audience includes radiologists and surgeons specializing in breast cancer diagnosis and treatment, as well as hospitals and clinics seeking to improve patient outcomes and reduce healthcare costs associated with breast biopsies.

Features

  • Single-use, sterile device designed for use by radiologists and surgeons
  • Ultrasound-guided for precise lesion targeting
  • Minimally invasive blunt dissection technique to reduce tissue damage and bleeding
  • Electrosurgical capabilities for fine cuts and immediate coagulation
  • Vacuum-assisted extraction to capture the entire lesion intact
  • Large tissue sample size (9 x 30 mm) for comprehensive histopathological examination
  • Potential for complete tumor removal during the initial procedure
  • Connects to standard diathermy equipment, avoiding the need for specialized vacuum generating units
This profile is AI-generated and may contain inaccuracies.